nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platform
|
Tumpach, Carolin |
|
|
9 |
2 |
p. |
artikel |
2 |
Antigen specificities of HIV-infected cells: A role in infection and persistence?
|
Faua, Clayton |
|
|
9 |
2 |
p. |
artikel |
3 |
Antiviral activity of silver nanoparticles against the influenza A virus
|
Naumenko, Krystyna |
|
|
9 |
2 |
p. |
artikel |
4 |
Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
|
Mehyar, Nimer |
|
|
9 |
2 |
p. |
artikel |
5 |
Editorial Board
|
|
|
|
9 |
2 |
p. |
artikel |
6 |
Editorial JVE 9.2
|
|
|
|
9 |
2 |
p. |
artikel |
7 |
Highlights of the first edition of the European Conference on Microbiota & Virology: A hybrid event, Paris, 23 March 2023
|
Psomas, Christina K. |
|
|
9 |
2 |
p. |
artikel |
8 |
HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption
|
Okumu, Eunice Akinyi |
|
|
9 |
2 |
p. |
artikel |
9 |
Perceived risks and benefits of enrolling people with HIV at the end of life in cure research in Southern California, United States
|
Dubé, Karine |
|
|
9 |
2 |
p. |
artikel |
10 |
Rate of occult hepatitis B virus infection among individuals with tuberculosis in northeastern Iran: A molecular epidemiological study
|
Ahmadi Ghezeldasht, Sanaz |
|
|
9 |
2 |
p. |
artikel |